Women’s experiences in injectable opioid agonist treatment programs in Vancouver, Canada

Injectable opioid agonist treatment (iOAT) has recently been expanded in some geographical contexts as part of a response to the escalating overdose crisis. The overdose crisis and drug treatment are shaped by complex gendered dynamics, including power differentials, violence, and social norms, that can adversely impact women’s experiences.

Drawing from a qualitative study of iOAT programs in Vancouver this presentation examined how social and structural factors impact women’s engagement with iOAT.

Speaker:

• Samara Mayer, University of British Columbia, BC Centre on Substance Use

Also Available

• Presentation slides in PDF format
• Research paper: Women's experiences in injectable opioid agonist treatment programs in Vancouver, Canada
• Also mentioned:
  • BCCSU Guidance for Injectable Opioid Agonist Treatment for Opioid Use Disorder
  • Co/Lab CoP: A Gendered Analysis of Prescribed Safer Supply in BC
  • Perinatal Injectable Opioid Agonist Therapy (iOAT) Administration: A Case Series
  • Kílala Lelum - Urban Indigenous Health and Healing Cooperative